Research Associate/Engineer I, Technical Development (2026 Rotation Program) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Moderna · 2 weeks ago

Research Associate/Engineer I, Technical Development (2026 Rotation Program)

Moderna is a leading company in mRNA technology, seeking talented individuals for its Technical Development Rotation Program. The role involves exploring various areas of mRNA therapeutic development through hands-on experience in manufacturing processes and collaboration with project teams.

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics
check
Comp. & Benefits
badNo H1BnoteU.S. Citizen Onlynote

Responsibilities

Work with a team of highly skilled experts to come up to speed on technology and techniques
Use laboratory, technical and communication skills to generate experimental results, perform data analysis, and document in formal reports including conclusions and recommended next steps
Perform process scale-up, support technology transfer and provide manufacturing support at internal Moderna, and external contract manufacturing sites
Participate in planning, design, execution, analysis of experiments and formal risk assessments to establish critical process parameters, and overall process control strategies
Optimize the impact of formulation and processing conditions on the stability of mRNA drug products and process intermediates
Review and share relevant academic literature and establish new collaborations with internal research and manufacturing groups
Create scaled-down models, and high throughput experimental setups for unit operations
Characterize mRNA and lipid nanoparticles through collaboration with the analytical team
Prepare technical reports and present finding in cross-functional meetings
Additional duties as may be assigned from time to time

Qualification

MRNA therapeutic developmentBioprocess developmentAnalytical methodsGxP regulationsData analysisLaboratory skillsCommunication skillsTeam collaborationIndependent work

Required

Bachelors or Masters Degree in Chemical Engineering, Biochemical Engineering, Bioengineering, Biomolecular Engineering, Chemistry, Biochemistry, Biomedical Engineering, Biophysics, Biostatistics, Biotechnology, Mathematics, Molecular Biology, Pharmaceutical Science, Statistics, or a related field preferred
Strong fundamental scientific and engineering skills for the evaluation of experimental data
Laboratory skills applicable to bioprocess development and analytical methods
At Moderna, we are focused on delivering on our mission by enabling talent to thrive. For this role, we are currently unable to offer immigration sponsorship. Candidates must already hold work authorization in US and be able to maintain that status without the need for future sponsorship
This position is site-based, requiring you to be at Moderna's site full-time. This position is not eligible for remote work

Preferred

GPA of 3.5 on a 4 scale or equivalent
Demonstrated ability to work both independently as well as the ability to contribute to high performing teams
Excellent written and verbal communication skills
Demonstrated aptitude or ability to learn in order to gain a strong understanding of GxP regulations (GxP, GMP, GLP)
A desire to make an impact as part of a high-growth, transformational company that is Bold, Relentless, Curious, and Collaborative

Benefits

Best-in-class healthcare coverage, plus voluntary benefit programs to support your unique needs
A holistic approach to well-being, with access to fitness, mindfulness, and mental health support
Family planning benefits, including fertility, adoption, and surrogacy support
Generous paid time off, including vacation, volunteer days, sabbatical, global recharge days, and a discretionary year-end shutdown
Savings and investment opportunities to help you plan for the future
Location-specific perks and extras

Company

Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.

Funding

Current Stage
Public Company
Total Funding
$4.56B
Key Investors
Coalition for Epidemic Preparedness InnovationsAres ManagementU.S. Department of Health & Human Services
2025-12-18Grant· $54.3M
2025-11-20Post Ipo Debt· $600M
2024-07-02Grant· $176M

Leadership Team

leader-logo
Stephane Bancel
Founding CEO
linkedin
leader-logo
Kenneth Chien
Co-Founder
linkedin
Company data provided by crunchbase